Abstract
Medulloblastomas are the most aggressive pediatric brain tumors originating from self-renewing common progenitor cells and associated with high rate of invasion along with rapid spread. The hereditary origin of these tumors can be studied to define it at genome level; however, to understand the molecular mechanism and pathogenesis, systems level investigation is required. In this study we used systems level analysis to identify molecular targets, pathways, molecular networks and functional modules associated with genes/proteins with altered expression in medulloblastoma. Molecular functions, annotated functions, associated pathways, networks and functional modules were identified with PANTHER, DAVID, Ingenuity Pathway Analysis, MetaCore and GeneSpring software analysis, respectively. P53 signaling, PI3K/AKT signaling, Notch signaling, Hedgehog signaling and HGF signaling were identified as significant pathways, indicating the signature of molecules involved in medulloblastoma. Network analysis using IPA revealed new set of molecules, HNRNPK, PDE4A, HES5, GSTP1, SLC16A2, and GADD45A, which also appeared as significant functional modules in GeneSpring analysis. The systems biology approach used in this study provides a comprehensive understanding of complex molecular alterations involved in medulloblastoma and reveals potential novel targets, which could be used for future targeted or personalized therapeutic interventions.
Keywords: Cell lines, functional modules, medulloblastoma, molecular networks, personalized medicine, systems biology.
Current Pharmacogenomics and Personalized Medicine
Title:Systems Biology Approach for the Identification of Diagnostic and Therapeutic Targets in Medulloblastomas
Volume: 11
Author(s): Aditi Kapoor, Vinayak Pachapur, Rekha Jain, Prateek Singh, Durairaj Renu, Jyoti Bajpai Dikshit and Sanjeeva Srivastava
Affiliation:
Keywords: Cell lines, functional modules, medulloblastoma, molecular networks, personalized medicine, systems biology.
Abstract: Medulloblastomas are the most aggressive pediatric brain tumors originating from self-renewing common progenitor cells and associated with high rate of invasion along with rapid spread. The hereditary origin of these tumors can be studied to define it at genome level; however, to understand the molecular mechanism and pathogenesis, systems level investigation is required. In this study we used systems level analysis to identify molecular targets, pathways, molecular networks and functional modules associated with genes/proteins with altered expression in medulloblastoma. Molecular functions, annotated functions, associated pathways, networks and functional modules were identified with PANTHER, DAVID, Ingenuity Pathway Analysis, MetaCore and GeneSpring software analysis, respectively. P53 signaling, PI3K/AKT signaling, Notch signaling, Hedgehog signaling and HGF signaling were identified as significant pathways, indicating the signature of molecules involved in medulloblastoma. Network analysis using IPA revealed new set of molecules, HNRNPK, PDE4A, HES5, GSTP1, SLC16A2, and GADD45A, which also appeared as significant functional modules in GeneSpring analysis. The systems biology approach used in this study provides a comprehensive understanding of complex molecular alterations involved in medulloblastoma and reveals potential novel targets, which could be used for future targeted or personalized therapeutic interventions.
Export Options
About this article
Cite this article as:
Kapoor Aditi, Pachapur Vinayak, Jain Rekha, Singh Prateek, Renu Durairaj, Dikshit Jyoti Bajpai and Srivastava Sanjeeva, Systems Biology Approach for the Identification of Diagnostic and Therapeutic Targets in Medulloblastomas, Current Pharmacogenomics and Personalized Medicine 2013; 11 (2) . https://dx.doi.org/10.2174/1875692111311020006
DOI https://dx.doi.org/10.2174/1875692111311020006 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Screening Neuroprotective Agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation Induced PC12 Injury Models: A Review
Current Psychopharmacology Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Current Pharmaceutical Biotechnology Regulation of Microtubule: Current Concepts and Relevance to Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Isolation, Characterization and Preliminary Cytotoxic and Antifungal Evaluations of Novel Lancifoliate Isolated from Methanol Extract of <i>Conocarpus lancifolius</i>
Anti-Cancer Agents in Medicinal Chemistry Curcumin: Not So Spicy After All
Mini-Reviews in Medicinal Chemistry The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases
Anti-Infective Agents in Medicinal Chemistry Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs
Current Cancer Drug Targets Preoperative Functional Magnetic Resonance Imaging (fMRI) and Transcranial Magnetic Stimulation (TMS)
Current Medical Imaging EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer
Current Drug Targets Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Current Medicinal Chemistry Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins
Current Pharmaceutical Design Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor
Current Pharmaceutical Design Iron Oxide Nanoparticles Synthesized Via Green Tea Extract for Doxorubicin Delivery
Current Nanoscience Radiation Induced Non-targeted Response: Mechanism and Potential Clinical Implications
Current Molecular Pharmacology Incorporating Link Information in Feature Selection for Identifying Tumor Biomarkers by Using miRNA-mRNA Paired Expression Data
Current Proteomics Blocking Ca2+ Entry: A Way to Control Cell Proliferation
Current Medicinal Chemistry Recent Advances in Transcranial Focused Ultrasound (FUS) Triggered Brain Delivery
Current Drug Targets Chalcones as Promising Lead Compounds on Cancer Therapy
Current Medicinal Chemistry Glutamate Dehydrogenase as a Promising Target for Hyperinsulinism Hyperammonemia Syndrome Therapy
Current Medicinal Chemistry Mass Spectrometric Imaging of the Nervous System
Current Pharmaceutical Design